SCHEMBL18421573

SCHEMBL18421573

N#Cc1cnccc1-c1cc[c]cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 4/20 0.42
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2D6 P10635 3/20 0.42
▸ CYP2C19 P33261 3/20 0.41
▸ CYP2E1 P05181 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ CYP2B6 P20813 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ GPR119 Q8TDV5 3/20 0.38
▸ PDE10A Q9Y233 1/20 0.37
▸ NCOA3 Q9Y6Q9 1/20 0.37
▸ LATS1 O95835 1/20 0.36
▸ LATS2 Q9NRM7 1/20 0.36
▸ LRRK2 Q5S007 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ PDE5A O76074 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18422231 0.85 CYP11B2 (0.40) CYP2C19HTTPDE10AKDM4EPDE5A
SCHEMBL1146097 0.83 CYP1A2 (0.57) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL31133690 0.82 HTT (0.48) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL17116602 0.81 CYP1A2 (0.42) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL3990856 0.80 LRRK2 (0.54) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL6626450 0.80 RPS6KA3 (0.47) CYP2A6CYP1A2CYP2D6KDM4EHPGD
SCHEMBL17116727 0.80 HTT (0.42) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL18423782 0.80 CYP2A6 (0.40) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL31038737 0.78 CYP2A6 (0.58) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1
SCHEMBL3237467 0.78 CYP2A6 (0.58) CYP2A6CYP1A2CYP2D6CYP2C19CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC26A3, SLC9A1, HVCN1 CYP2A6 1528/4885CYP1A2 965/4885CYP2D6 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback